Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis (2019)
Attributed to:
MICA: Targeting neuro-inflammation in Schizophrenia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41386-019-0577-3
PubMed Identifier: 31766049
Publication URI: http://europepmc.org/abstract/MED/31766049
Type: Journal Article/Review
Parent Publication: Neuropsychopharmacology
Issue: 4
ISSN: 0893-133X